Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
| CEO | Vasant Narasimhan |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 110,000 |
| Date Founded | 1996 |
| Headquarters | East Hanover, New Jersey |
| Number of Locations | 29 |
| Revenue | $51.7B |
| Net Income | US$8.07 billion (2020) [2] |
| Gross Proft | $38.9B (2024) |
| PE Ratio | 16.20 |
| Tax Rate | 0.1% |
| Market Capitalization | $193.5B |
| Total Assets | US$132.06 billion (2020) [2] |
| Ticker | NVS |
Novartis's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.
Novartis's smallest competitor is Falcon Pharmaceuticals Ltd with revenue of $19.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| AstraZeneca | $112,988 | $25.9B | 76,100 | 394 |
| Eli Lilly and Company | $100,905 | $45.0B | 33,625 | 786 |
| Merck | $90,328 | $64.2B | 74,000 | 1,726 |
| Glaxosmithkline | $68,587 | $34.1B | 99,000 | 2 |
| Boehringer Ingelheim | $106,981 | $17.2B | 52,391 | 387 |
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 1,825 |
| Sanofi US | $88,931 | $980.0M | 110,000 | 748 |
| Falcon Pharmaceuticals Ltd | $65,030 | $19.0M | 30 | - |
| Takeda Pharmaceuticals U.S.A., Inc. | $85,837 | $12.1B | 30,481 | 1,231 |
| Pfizer | $70,868 | $63.6B | 78,500 | 546 |
Zippia gives an in-depth look into the details of Novartis, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Novartis. The employee data is based on information from people who have self-reported their past or current employments at Novartis. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Novartis. The data presented on this page does not represent the view of Novartis and its employees or that of Zippia.
Novartis may also be known as or be related to Novartis, Novartis Corporation, Novartis US Foundation and Novartis Vaccines and Diagnostics, Inc.